Delivery Order SPE2DB22D3501-SPE2DB24FVM32
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $6,609.40 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product. This delivery order contract has a final completion date of December 6, 2023 and is a firm fixed-price arrangement. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major...
- The Defense Logistics Agency (DLA) awarded a $9,154.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Dupixent 300 mg/2 ml pens. This contract has an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,966.99 firm fixed-price delivery order is for the supply of Dupixent 200 mg/1.14 ml pens. The contract has an ultimate completion date of October 25, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,873.54, is for the delivery of Dupixent 300 mg/2 ml pens. This is a firm-fixed-price delivery order with a completion date of January 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,267.53, is for the delivery of Dupixent 300 mg/2 ml pens. This is a firm fixed-price delivery order contract with an ultimate completion date of January 29, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,126.42 fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, a specialized pharmaceutical product. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,167.61, is a delivery order for Dupixent 300 mg/2 ml pens. The award has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,860.27 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 200 mg/1.14 ml pens. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $32,672.79 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of August 2, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States, providing a wide range of medical commodities to federal agencies and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Dupixent 300 mg/2 ml pen in the amount of $9,914.10. The order has a firm fixed price and an ultimate completion date of May 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVM32Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $9,857.88 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 300 mg/2 ml Dupixent pens, a specialty pharmaceutical product. The award has an ultimate completion date of May 1, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 4/30/24 |